S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Bank Accounts: Frozen! (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
Bank Accounts: Frozen! (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Bank Accounts: Frozen! (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Bank Accounts: Frozen! (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
Bank Accounts: Frozen! (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Bank Accounts: Frozen! (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Bank Accounts: Frozen! (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
Bank Accounts: Frozen! (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Bank Accounts: Frozen! (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
Bank Accounts: Frozen! (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
Bank Accounts: Frozen! (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Bank Accounts: Frozen! (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
NASDAQ:CRVS

Corvus Pharmaceuticals - CRVS Institutional Ownership

$0.68
0.00 (0.00%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.65
▼
$0.70
50-Day Range
$0.65
▼
$0.91
52-Week Range
$0.61
▼
$2.11
Volume
31,475 shs
Average Volume
96,408 shs
Market Capitalization
$31.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

Institutional Ownership Changes (13F Filings) for Corvus Pharmaceuticals (NASDAQ:CRVS)

Current
Institutional Ownership
Percentage
47.45%
Number of
Institutional Buyers
(last 12 months)
12
Total
Institutional Inflows
(last 12 months)
$1.12 M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$1.36 M
Skip Chart & View Institutional Buying and Selling Data

CRVS Institutional Buying and Selling by Quarter

Get CRVS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Corvus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Corvus Pharmaceuticals Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2023Millennium Management LLC1,899,516$1.62M0.0%-16.1%4.080%
2/15/2023Morgan Stanley72,605$62K0.0%+84.7%0.156%
2/14/2023Two Sigma Investments LP281,187$0.24M0.0%-34.6%0.604%
2/14/2023Discovery Capital Management LLC CT548,727$0.47M0.1%N/A1.179%
2/13/2023Renaissance Technologies LLC648,632$0.55M0.0%-33.5%1.393%
11/17/2022Telemetry Investments L.L.C.522,009$0.43M0.5%+13.5%1.121%
11/15/2022Two Sigma Advisers LP480,100$0.39M0.0%+28.6%1.031%
11/15/2022Two Sigma Investments LP429,708$0.35M0.0%+19.0%0.923%
11/14/2022Renaissance Technologies LLC975,519$0.80M0.0%+1.3%2.095%
11/10/2022Dimensional Fund Advisors LP37,051$30K0.0%-84.1%0.080%
10/18/2022Bailard Inc.39,998$33K0.0%N/A0.086%
8/18/2022Goldman Sachs Group Inc.39,850$39K0.0%-43.6%0.086%
8/15/2022Millennium Management LLC2,687,943$2.66M0.0%-1.3%5.774%
8/13/2022Renaissance Technologies LLC962,932$0.95M0.0%+6.9%2.068%
5/27/2022Walleye Capital LLC15,080$25K0.0%-43.3%0.032%
5/17/2022Walleye Capital LLC15,080$25K0.0%-43.3%0.032%
5/16/2022Goldman Sachs Group Inc.70,595$0.12M0.0%-33.3%0.152%
5/16/2022State Street Corp112,603$0.19M0.0%+12.2%0.242%
5/13/2022Renaissance Technologies LLC901,132$1.48M0.0%-13.7%1.936%
5/13/2022Vanguard Group Inc.1,267,752$2.08M0.0%+2.9%2.723%
5/13/2022Dimensional Fund Advisors LP419,140$0.69M0.0%-11.8%0.900%
5/12/2022Acadian Asset Management LLC140,118$0.23M0.0%+72.6%0.301%
4/20/2022Jackson Square Capital LLC63,773$0.11M0.0%N/A0.137%
4/13/2022Hikari Power Ltd49,959$82K0.0%+150.3%0.107%
2/15/2022Coastal Bridge Advisors LLC24,000$58K0.0%N/A0.052%
2/14/2022Point72 Asset Management L.P.795,000$1.92M0.0%+38.3%1.708%
2/10/2022Acadian Asset Management LLC81,166$0.19M0.0%+96.9%0.174%
11/22/2021EcoR1 Capital LLC2,081,077$10.07M0.4%-41.9%4.471%
11/16/2021Squarepoint Ops LLC19,954$97K0.0%N/A0.043%
11/16/2021Tang Capital Management LLC3,749,379$18.15M3.8%N/A8.055%
11/16/2021Two Sigma Investments LP140,455$0.68M0.0%-54.6%0.302%
11/16/2021Two Sigma Securities LLC22,789$0.11M0.0%N/A0.049%
11/16/2021Telemetry Investments L.L.C.196,168$0.95M1.3%-25.7%0.421%
11/16/2021VR Adviser LLC3,427,461$16.59M2.1%N/A7.363%
11/16/2021BVF Inc. IL1,370,947$6.64M0.3%-62.7%2.945%
11/16/2021CHI Advisors LLC165,927$0.80M0.2%-76.9%0.356%
11/15/2021Point72 Asset Management L.P.575,000$2.78M0.0%N/A1.235%
11/15/2021Pura Vida Investments LLC734,268$3.55M0.1%N/A1.577%
11/15/2021Zacks Investment Management10,000$48K0.0%N/A0.021%
11/12/2021Affinity Asset Advisors LLC50,000$0.24M0.1%N/A0.107%
11/12/2021Renaissance Technologies LLC614,370$2.97M0.0%-6.6%1.320%
11/12/2021DC Investments Management LLC50,709$0.25M0.5%N/A0.109%
11/12/2021MYDA Advisors LLC60,000$0.29M0.1%N/A0.129%
11/12/2021Geode Capital Management LLC210,243$1.02M0.0%+10.9%0.452%
11/12/2021Artal Group S.A.500,000$2.42M0.1%N/A1.074%
11/9/2021BlackRock Inc.100,451$0.49M0.0%-23.3%0.216%
11/5/2021Lindbrook Capital LLC14,000$68K0.0%N/A0.033%
8/17/2021BVF Inc. IL3,678,626$9.82M0.4%+13.9%8.672%
8/16/2021Telemetry Investments L.L.C.263,975$0.71M1.0%+6.0%0.622%
8/16/2021State Street Corp29,600$79K0.0%N/A0.070%
8/13/2021Renaissance Technologies LLC658,070$1.76M0.0%-0.8%1.551%
8/13/2021Northern Trust Corp59,262$0.16M0.0%+56.5%0.140%
8/13/2021Laurion Capital Management LP59,150$0.16M0.0%-79.0%0.139%
8/13/2021Algert Global LLC19,737$53K0.0%-53.9%0.047%
8/13/2021Natixis27,900$74K0.0%+69.1%0.066%
8/13/2021Geode Capital Management LLC189,541$0.51M0.0%+27.4%0.447%
8/13/2021Vanguard Group Inc.1,109,218$2.96M0.0%+10.9%2.615%
8/12/2021Dimensional Fund Advisors LP395,829$1.06M0.0%-5.0%0.933%
8/11/2021CHI Advisors LLC719,132$1.92M0.4%+5.9%1.695%
5/18/2021BVF Inc. IL3,229,426$9.95M0.4%+66.1%8.430%
5/18/2021Millennium Management LLC99,096$0.31M0.0%-18.5%0.259%
5/18/2021Orbimed Advisors LLC8,053,298$24.80M0.2%+19.0%21.021%
5/17/2021Ikarian Capital LLC100,000$0.31M0.0%N/A0.261%
5/17/2021Goldman Sachs Group Inc.30,804$95K0.0%-62.3%0.080%
5/14/2021Laurion Capital Management LP282,132$0.87M0.0%N/A0.736%
5/14/2021Dimensional Fund Advisors LP416,649$1.28M0.0%-4.5%1.088%
5/14/2021Algert Global LLC42,857$0.13M0.0%+177.1%0.112%
5/13/2021Renaissance Technologies LLC663,470$2.04M0.0%-16.8%1.732%
5/12/2021Northern Trust Corp37,878$0.12M0.0%+28.6%0.099%
5/12/2021Geode Capital Management LLC148,834$0.46M0.0%+34.5%0.388%
5/11/2021Mercer Global Advisors Inc. ADV10,500$32K0.0%N/A0.027%
5/11/2021Acadian Asset Management LLC20,936$64K0.0%-77.4%0.055%
5/10/2021GSA Capital Partners LLP95,613$0.29M0.0%N/A0.250%
5/10/2021Bank Julius Baer & Co. Ltd Zurich336,748$1.04M0.0%N/A0.879%
5/7/2021BlackRock Inc.77,668$0.24M0.0%+11.3%0.203%
5/4/2021Envestnet Asset Management Inc.10,500$32K0.0%N/A0.027%
2/18/2021Truist Financial Corp21,000$75K0.0%N/A0.075%
2/12/2021CHI Advisors LLC490,877$1.75M0.5%-15.8%1.749%
2/10/2021Renaissance Technologies LLC797,070$2.84M0.0%-8.9%2.840%
2/5/2021BlackRock Inc.69,810$0.25M0.0%-56.8%0.249%
1/25/2021Golden Green Inc.19,539$70K0.1%N/A0.070%
11/13/2020Morgan Stanley32,746$0.13M0.0%+117.7%0.117%
11/9/2020Acadian Asset Management LLC157,134$0.63M0.0%-13.5%0.560%
11/6/2020BlackRock Inc.161,549$0.65M0.0%-48.0%0.576%
10/8/2020Hikari Power Ltd19,959$80K0.0%-67.3%0.071%
9/15/2020Two Sigma Advisers LP36,880$100K0.0%+27.7%0.132%
8/14/2020BVF Inc. IL1,742,112$4.74M0.3%-19.2%6.214%
8/5/2020Russell Investments Group Ltd.39,171$0.11M0.0%+29.6%0.140%
5/15/2020Squarepoint Ops LLC24,436$52K0.0%N/A0.087%
5/15/2020Morgan Stanley32,920$69K0.0%-14.8%0.118%
5/15/2020Two Sigma Investments LP99,258$0.21M0.0%-8.6%0.355%
5/15/2020Two Sigma Advisers LP28,880$61K0.0%+74.2%0.103%
5/13/2020Connor Clark & Lunn Investment Management Ltd.85,604$0.18M0.0%+4.7%0.306%
5/6/2020Russell Investments Group Ltd.30,220$63K0.0%N/A0.108%
4/23/2020Hikari Power Ltd60,959$0.13M0.0%-23.8%0.218%
3/2/2020Connor Clark & Lunn Investment Management Ltd.81,800$0.45M0.0%+9.5%0.278%
2/20/2020Geode Capital Management LLC137,555$0.75M0.0%+6.3%0.468%
2/18/2020EcoR1 Capital LLC737,612$4.01M0.4%N/A2.508%
2/14/2020BVF Inc. IL1,627,568$8.85M0.7%-46.6%5.535%
2/14/2020Bank of America Corp DE22,811$0.12M0.0%-51.9%0.078%
(Data available from 1/1/2016 forward)













CRVS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CRVS shares?

During the previous two years, 44 institutional investors and hedge funds held shares of Corvus Pharmaceuticals. The most heavily invested institutionals were Orbimed Advisors LLC ($24.80M), Tang Capital Management LLC ($18.15M), VR Adviser LLC ($16.59M), EcoR1 Capital LLC ($10.07M), BVF Inc. IL ($6.64M), Pura Vida Investments LLC ($3.55M), and Artal Group S.A. ($2.42M).Learn more on CRVS's institutional investors.

What percentage of Corvus Pharmaceuticals stock is owned by institutional investors?

47.45% of Corvus Pharmaceuticals stock is owned by institutional investors. Learn more on CRVS's institutional investor holdings.

Which institutional investors have been buying Corvus Pharmaceuticals stock?

Of the 39 institutional investors that purchased Corvus Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Tang Capital Management LLC ($3.75M), VR Adviser LLC ($3.43M), BVF Inc. IL ($1.73M), Orbimed Advisors LLC ($1.29M), Point72 Asset Management L.P. ($0.80M), Pura Vida Investments LLC ($0.73M), and Discovery Capital Management LLC CT ($0.55M).

How much institutional buying is happening at Corvus Pharmaceuticals?

Institutional investors have bought a total of 14,857,942 shares in the last 24 months. This purchase volume represents approximately $59.16M in transactions.

Which Corvus Pharmaceuticals major shareholders have been selling company stock?

Of the 14 institutional investors that sold Corvus Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BVF Inc. IL ($2.31M), EcoR1 Capital LLC ($1.50M), Renaissance Technologies LLC ($0.65M), CHI Advisors LLC ($0.55M), Millennium Management LLC ($0.42M), Two Sigma Investments LP ($0.32M), and Dimensional Fund Advisors LP ($0.29M).

How much institutional selling is happening at Corvus Pharmaceuticals?

Institutional investors have sold a total of 6,600,951 shares in the last 24 months. This volume of shares sold represents approximately $25.61M in transactions.

This page (NASDAQ:CRVS) was last updated on 3/25/2023 by MarketBeat.com Staff